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Microparticles are small fragments of the plasma membrane generated after cell
stimulation. We recently showed that Sonic hedgehog (Shh) is present in
microparticles generated from activated/apoptotic human T lymphocytes and corrects
endothelial injury through nitric oxide (NO) release. This study investigates whether
microparticles bearing Shh correct angiotensin II-induced hypertension and
endothelial dysfunction in mice. Male Swiss mice were implanted with osmotic
minipumps delivering angiotensin II (0.5 mg/kg/day) or NaCl (0.9%). Systolic blood
pressure and heart rate were measured daily during 21 days. After 7 day of
minipump implantation, mice received i.v. injections of microparticles (10 µg/ml)
or i.p. Shh receptor antagonist cyclopamine (10 mg/kg/2 days) during one week.
Angiotensin II induced a significant rise in systolic blood pressure without affecting
heart rate. Microparticles reversed angiotensin II-induced hypertension, and
cyclopamine prevented the effects of microparticles. Microparticles completely
corrected the impairment of acetylcholine- and flow-induced relaxation in vessels
from angiotensin II-infused mice. The improvement of endothelial function induced
by microparticles was completely prevented by cyclopamine treatment. Moreover,
microparticles alone did not modify NO and O2. - production in aorta, but
significantly increased NO and reduced O2. - productions in aorta from angiotensin
II-treated mice, and these effects were blocked by cyclopamine. Altogether, these
results show that microparticles bearing Shh correct angiotensin II-induced
hypertension and endothelial dysfunction in aorta through a mechanism associated
with Shh-induced NO production and reduction of oxidative stress. These
microparticles may represent a new therapeutic approach in cardiovascular diseases
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